Get the latest news, insights, and market updates on CVAC (CureVac N.V.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Immatics (IMTX) Reports Q3 Loss, Misses Revenue Estimates
Immatics (IMTX) delivered earnings and revenue surprises of +2.00% and -50.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock? Nov 17, 2025 - $CVAC
CureVac (NasdaqGM:CVAC): Exploring Valuation After Strong Share Price Gains in 2024
CureVac (NasdaqGM:CVAC) shares have had a quiet week, trading near $5.28 after some earlier rebounds this year. Investors are watching the stock’s recent performance because a 53% gain year to date is sparking questions about sustainability. See our latest analysis for CureVac. It has been a standout year for CureVac’s share price, which is holding onto a 53% gain since January, even as momentum has cooled a little in recent weeks. The company’s 12-month total shareholder return is even more... Nov 17, 2025 - $CVAC
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of -12.50% and +1.69%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock? Nov 14, 2025 - $CVAC
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next milestone in the execution of its oncology strategyCureVac shareholders receive approximately $5.46 in BioNTech American Depositary Shares for each CureVac share, subject to a collar; an indicative exchange ratio will be available at www.envisionreports.com/CureVacOffer for the duration of the exchange offerInformation on how CureVac Oct 22, 2025 - $CVAC
CureVac (NasdaqGM:CVAC) Valuation in Focus After Recent Share Price Movements
CureVac (NasdaqGM:CVAC) Catches Investors’ Eyes: What’s Behind the Move? CureVac (NasdaqGM:CVAC) is back on the radar for many investors after recent moves in its share price have raised fresh questions about the company’s outlook. Although there hasn’t been a single headline-making event, it is often these quieter stretches that spark discussions around what the market is really signaling and whether an inflection point is taking shape for the stock. This kind of environment can nudge... Sep 13, 2025 - $CVAC
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple